Carnegie Capital Asset Management, LLC Moderna, Inc. Transaction History

Carnegie Capital Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$135.66 - $197.02 $269,963 - $392,069	1,990 New	1,990 $305,000
Q2 2022 Jul 13, 2022	BUY	$117.13 - $176.59 $275,255 - $414,986	2,350 New	2,350 $552,000
Q4 2021 Jan 21, 2022	SELL	$225.82 - $368.51 $214,529 - $350,084	-950 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$221.9 - $484.47 $310,660 - $678,258	-1,400 Reduced 59.57%	950 $366,000
Q2 2021 Jul 16, 2021	SELL	$129.91 - $234.98 $84,441 - $152,737	-650 Reduced 21.67%	2,350 $552,000
Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $259,672 - $670,947	-3,950 Reduced 56.83%	3,000 $313,000
Q3 2020 Oct 13, 2020	BUY	$54.34 - $94.85 $137,371 - $239,780	2,528 Added 57.17%	6,950 $492,000
Q2 2020 Jul 09, 2020	BUY	$29.67 - $80.0 $131,200 - $353,760	4,422 New	4,422 $284,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.